————————————————————
If your insurance card says “CVS Caremark” on it, you are one of well over 100 million Americans whose prescription drug benefits are managed by this company. So what is CVS Caremark, exactly? It is the pharmacy benefit management division of CVS Health — a large healthcare company that also owns CVS Pharmacy stores and the health insurer Aetna. That combination means CVS Caremark can influence which drugs are affordable for you, which pharmacies offer the best deal on your plan, and whether a given medication needs extra approval before it is covered. This article is a neutral, factual overview to help you understand how the system works.
CVS Caremark’s Role as a PBM
CVS Caremark is a pharmacy benefit manager (PBM) — a company that acts as an intermediary between health insurance plans, pharmacies, and drug manufacturers. When an employer or insurer needs someone to manage the pharmacy side of its health benefits, it may hire a PBM such as CVS Caremark to do it.
Broadly, a PBM negotiates rebates with drug manufacturers in exchange for favorable formulary placement, builds the list of drugs a plan covers, contracts with pharmacies to create a network, processes claims when members fill prescriptions, and runs utilization-management programs such as prior authorization and step therapy. CVS Caremark is one of the “Big Three” PBMs alongside Express Scripts (part of Cigna) and OptumRx (part of UnitedHealth Group). According to analyses summarized by KFF and the FTC, these three PBMs together administer the large majority of US prescription claims.
How CVS Caremark Affects Your Prescription Costs
Understanding what CVS Caremark does starts with the formulary. Your formulary is the list of medications your plan covers, organized into cost tiers. CVS Caremark and other PBMs typically structure these tiers roughly as follows (exact copays are set by your specific plan and can vary widely):
Tier 1: Preferred generics — usually the lowest copay, often around $5 to $15 for a 30-day supply.
Tier 2: Non-preferred generics and preferred brand-name drugs — moderate copays, often in the range of $25 to $50.
Tier 3: Non-preferred brand-name drugs — higher copays, sometimes $75 or more.
Tier 4 / Specialty: Specialty medications — often subject to coinsurance (a percentage of the drug’s cost) rather than a flat copay, which can reach hundreds of dollars per fill.
The tier a medication lands on is influenced significantly by the rebates a PBM negotiates with manufacturers. A drug with a high list price but a generous rebate can sometimes sit on a lower tier than a moderately priced drug with no rebate. Because of this, your out-of-pocket cost does not always track the actual price of the medication — a dynamic that is at the center of much of the current debate over PBM transparency.
The CVS Health Vertical Integration
What makes CVS Caremark notable among PBMs is the degree of vertical integration within CVS Health. The parent company owns:
CVS Pharmacy: Thousands of retail pharmacy locations nationwide (historically reported in the neighborhood of 9,000, though the company has been closing some stores in recent years). This is where many CVS Caremark members fill prescriptions, sometimes at lower copays than at non-CVS pharmacies.
Aetna: A major health insurer serving tens of millions of members. Aetna plans frequently use CVS Caremark as their PBM.
CVS Specialty: A specialty pharmacy that handles high-cost medications for complex conditions.
MinuteClinic and health services: In-store clinics and related health services that extend the company’s reach into primary and convenient care.
This structure lets CVS Health touch a patient’s experience from insurance coverage through prescription fulfillment, largely within its own ecosystem. Proponents argue that this integration creates efficiencies and coordination. Critics worry it can reduce competition and create incentives to steer patients toward CVS-owned services. The Federal Trade Commission’s 2024 interim staff report on PBMs raised specific concerns about vertical integration and its potential effects on patient choice and pharmacy competition.
CVS Caremark Mail Order and Specialty Pharmacy
CVS Caremark operates a mail-order pharmacy that delivers 90-day supplies of maintenance medications to your door. For chronic conditions that require daily medication, mail order often costs less than three separate retail fills, though this depends on your plan’s design. Standard shipping is typically free, and orders generally arrive within a few business days.
Specialty medications are usually handled through CVS Specialty. These are high-cost drugs — often biologics or advanced therapies — used for conditions such as cancer, rheumatoid arthritis, or multiple sclerosis. CVS Specialty provides clinical support, including nurses who help patients manage side effects and adherence. Many employer plans require specialty drugs to be filled through CVS Specialty rather than a retail pharmacy, a practice that has drawn attention in the PBM-reform debate.
Prior Authorization and Step Therapy
CVS Caremark uses utilization-management tools to control drug spending. Two of the most common are prior authorization and step therapy.
Prior authorization requires your prescriber to get approval from CVS Caremark before the plan will cover certain medications. This typically applies to expensive drugs, medications with safety considerations, or drugs where a lower-cost therapeutic alternative exists. Your prescriber submits clinical documentation explaining why the medication is necessary, and CVS Caremark responds with a coverage decision.
Step therapy requires you to try a less expensive medication first — and have it prove ineffective or intolerable — before the plan will cover a more expensive option. For example, a plan might require a trial of metformin for type 2 diabetes before covering a newer, costlier GLP-1 medication. If the first-line option does not work or causes intolerable side effects, your prescriber documents that, and CVS Caremark may then authorize the alternative.
PBM Scrutiny: The FTC and Reform Debate
PBMs — including CVS Caremark — have faced intensifying regulatory scrutiny. In July 2024, the FTC released its first interim staff report, provocatively titled “The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies,” which examined how the Big Three PBMs’ size and vertical integration affect drug prices and independent pharmacies. In January 2025, the FTC issued a second interim staff report focused on specialty generic drugs, reporting that the Big Three PBMs marked up numerous specialty generic drugs dispensed through their affiliated pharmacies by hundreds to thousands of percent, and estimating billions of dollars in dispensing revenue above estimated acquisition costs over the period studied.
Separately, in September 2024 the FTC brought an administrative enforcement action against the three largest PBMs and their affiliated group purchasing organizations over rebate practices related to insulin, alleging those practices contributed to inflated list prices. The PBMs have disputed the allegations, and the matter has been the subject of ongoing legal proceedings. The details and outcomes of these actions continue to evolve, and this article does not take a position on their merits — it simply notes that PBM practices are under active federal and state review, and that PBM reform legislation at both levels seeks to improve transparency and rein in some of these practices.
Common Complaints About CVS Caremark
Independent pharmacists frequently cite CVS Caremark as a source of frustration. Reimbursement rates — the amount a PBM pays a pharmacy for dispensing a drug — can sometimes fall below the pharmacy’s acquisition cost. The National Community Pharmacists Association has documented instances of below-cost reimbursements from major PBMs, including CVS Caremark.
Patients sometimes report being steered toward CVS-owned pharmacies through plan designs that charge higher copays at competitors. Litigation by independent pharmacies has alleged that CVS Caremark used preferential pricing to drive patients toward CVS Pharmacy locations, allegations that CVS Health has disputed.
Transparency remains a recurring concern. Employers who hire CVS Caremark often have limited visibility into the rebates the PBM negotiates and how much it retains. This opacity is one of the main issues that PBM-reform efforts at the state and federal level are trying to address.
Frequently Asked Questions
Is CVS Caremark the same as CVS Pharmacy?
No. CVS Caremark is the pharmacy benefit management company; CVS Pharmacy is the retail drugstore chain. Both are owned by CVS Health, but they serve different functions. CVS Caremark manages drug benefits and processes claims, while CVS Pharmacy dispenses medications. You can generally use your CVS Caremark benefits at non-CVS pharmacies that are in your plan’s network.
How do I find out if my drug is covered by CVS Caremark?
Log into your account at Caremark.com and use the drug cost and coverage tool. Enter the medication name to see your estimated copay, tier placement, and any coverage restrictions such as prior authorization or step therapy. You can also call the member services number on your prescription card for help.
Can I use GoodRx instead of CVS Caremark?
Yes. If the cash price using a discount card such as GoodRx is lower than your CVS Caremark copay, you can choose to pay cash instead. Keep in mind that cash payments usually do not count toward your plan’s deductible or out-of-pocket maximum, so compare both the immediate price and the longer-term implications before deciding.
What is CVS Caremark’s customer service number?
The member services number is printed on your prescription ID card, and that is the most reliable number to use because it routes to the team for your specific plan. CVS Caremark also offers support through the Caremark website and its mobile app. Because phone numbers can change by plan and over time, use the number on your card rather than an old one you may have saved.
Why do PBMs like CVS Caremark exist at all?
PBMs emerged to handle the administrative complexity of drug benefits — processing millions of claims, building pharmacy networks, and negotiating with manufacturers on behalf of plans. Supporters say they use scale to secure lower net prices; critics argue their business model and lack of transparency can raise costs for some patients and squeeze pharmacies. Both perspectives are part of the current policy debate.
The bottom line: CVS Caremark is the pharmacy benefit manager (PBM) arm of CVS Health, and it shapes your drug costs through formulary tiers, manufacturer rebates, pharmacy networks, claims processing, and tools like prior authorization and step therapy. Its position inside a vertically integrated company — alongside CVS Pharmacy, Aetna, and CVS Specialty — is a central theme in the PBM-reform debate and in the FTC’s 2024-2025 reports and enforcement actions. Nothing here is financial or medical advice: check your formulary each plan year, compare retail versus mail-order and cash prices, and work with your prescriber if a medication is denied. For broader context, explore our healthcare policy guide.
Sources
- Federal Trade Commission (FTC) — Pharmacy Benefit Managers: interim staff report (July 2024) and second interim staff report on specialty generic drugs (January 2025); FTC PBM enforcement actions
- KFF (Kaiser Family Foundation) — explainers on pharmacy benefit managers and prescription drug costs
- CVS Health — corporate disclosures on CVS Caremark, CVS Pharmacy, Aetna, and CVS Specialty
- National Community Pharmacists Association (NCPA) — reporting on PBM reimbursement practices